XBiotech XBIT Estimates

NASDAQ XBIT
$2.18 +0.03 (+1.40%)
At close: Sep 29, 2026 · 4:00 PM EDT
Analyst Estimates

XBiotech Inc. Revenue Estimates

Periods 16
Next Period Q1 21
Consensus 6.77 M

Analysts expect XBiotech Inc. to report revenue of 6.77 M for Q1 21, against a range of 6.49 M to 7.04 M.

Metric Q1 21Q2 21Q3 21Q4 21Q1 22Q2 22Q3 22Q4 22Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24
Reported (Actual) --------
High Estimate 7.04 M7.96 M7.83 M6.91 M7.28 M7.78 M7.54 M7.15 M
Low Estimate 6.49 M6.73 M6.92 M6.39 M6.32 M6.54 M6.84 M6.33 M
Consensus Estimate 6.77 M7.35 M7.38 M6.65 M6.80 M7.16 M7.19 M6.74 M
Analyst Estimates

XBiotech Inc. Earnings Per Share (EPS) Estimates

Periods 20
Next Period Q1 21
Consensus 0.04

Analysts expect XBiotech Inc. to report earnings per share of 0.04 for Q1 21, against a range of 0.04 to 0.04. The most recent reported quarter, Q4 25, came in at -0.88, a 100.5% miss against the -0.44 consensus.

Metric Q1 21Q2 21Q3 21Q4 21Q1 22Q2 22Q3 22Q4 22Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25
Reported (Actual) ---------0.36-0.06-0.20-0.88
High Estimate 0.040.030.030.02-0.27-0.27-0.28-0.25-0.41-0.42-0.42-0.40
Low Estimate 0.040.030.030.02-0.31-0.31-0.30-0.29-0.45-0.46-0.46-0.48
Consensus Estimate 0.040.030.030.02-0.29-0.29-0.29-0.27-0.43-0.44-0.44-0.44

XBiotech Inc. Estimates API

Pull Wall Street consensus for XBiotech Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=XBIT&mode=revenue&api_key=YOUR_API_KEY